Furuichi Kengo, Shimizu Miho, Hara Akinori, Toyama Tadashi, Wada Takashi
Division of Nephrology, Kanazawa University Hospital, Japan.
Intern Med. 2018 Dec 1;57(23):3345-3350. doi: 10.2169/internalmedicine.1132-18. Epub 2018 Aug 10.
Diabetic kidney disease is the main cause of end-stage kidney disease. However, the clinical manifestations of diabetic kidney disease are diverse. Therefore, the clinical classification of diabetic kidney disease is clinically important and valuable. In Japan, two clinical staging systems divided by the estimated glomerular filtration rate (eGFR) and albuminuria can be used for diabetic kidney disease: the chronic kidney disease (CKD) risk classification and the Japanese classification of diabetic nephropathy. The Japanese classification of diabetic nephropathy and the CKD risk classification are similar; however, these two classification systems show different frequencies of outcomes. For example, the frequency of the kidney outcomes in stage 4 of the Japanese classification of diabetic nephropathy was found to be higher than that in the red stage of the CKD risk classification (composite kidney events: stage 4=32.0/100 person-years, red =14.5/100 person-years). However, there were no marked differences in the speed or rate of decline in the kidney function (speed: stage 4=6.8 mL/min/1.73 m/year, red =5.8 mL/min/1.73 m/year; rate: stage 4=38.8%/year, red =34.3%/year) or in the pathological changes between the two classifications. These data indicate that each stage of these clinical classification systems has characteristic clinical and pathological features. Therefore, it is important to understand each characteristic feature and use each classification system appropriately.
糖尿病肾病是终末期肾病的主要病因。然而,糖尿病肾病的临床表现多种多样。因此,糖尿病肾病的临床分类在临床上具有重要意义和价值。在日本,可根据估计肾小球滤过率(eGFR)和蛋白尿对糖尿病肾病采用两种临床分期系统:慢性肾脏病(CKD)风险分类和日本糖尿病肾病分类。日本糖尿病肾病分类与CKD风险分类相似;然而,这两种分类系统显示出不同的结局频率。例如,发现日本糖尿病肾病分类4期的肾脏结局频率高于CKD风险分类红色期(复合肾脏事件:4期=32.0/100人年,红色期=14.5/100人年)。然而,在肾功能下降的速度或速率(速度:4期=6.8 mL/min/1.73 m/年,红色期=5.8 mL/min/1.73 m/年;速率:4期=38.8%/年,红色期=34.3%/年)或两种分类之间的病理变化方面没有明显差异。这些数据表明,这些临床分类系统的每个阶段都有其特征性的临床和病理特征。因此,了解每个特征并适当使用每个分类系统很重要。